Literature DB >> 22791940

Pathogenesis of achalasia cardia.

Uday C Ghoshal1, Sunil B Daschakraborty, Renu Singh.   

Abstract

Achalasia cardia is one of the common causes of motor dysphagia. Though the disease was first described more than 300 years ago, exact pathogenesis of this condition still remains enigmatic. Pathophysiologically, achalasia cardia is caused by loss of inhibitory ganglion in the myenteric plexus of the esophagus. In the initial stage, degeneration of inhibitory nerves in the esophagus results in unopposed action of excitatory neurotransmitters such as acetylcholine, resulting in high amplitude non-peristaltic contractions (vigorous achalasia); progressive loss of cholinergic neurons over time results in dilation and low amplitude simultaneous contractions in the esophageal body (classic achalasia). Since the initial description, several studies have attempted to explore initiating agents that may cause the disease, such as viral infection, other environmental factors, autoimmunity, and genetic factors. Though Chagas disease, which mimics achalasia, is caused by an infective agent, available evidence suggests that infection may not be an independent cause of primary achalasia. A genetic basis for achalasia is supported by reports showing occurrence of disease in monozygotic twins, siblings and other first-degree relatives and occurrence in association with other genetic diseases such as Down's syndrome and Parkinson's disease. Polymorphisms in genes encoding for nitric oxide synthase, receptors for vasoactive intestinal peptide, interleukin 23 and the ALADIN gene have been reported. However, studies on larger numbers of patients and controls from different ethnic groups are needed before definite conclusions can be obtained. Currently, the disease is believed to be multi-factorial, with autoimmune mechanisms triggered by infection in a genetically predisposed individual leading to degeneration of inhibitory ganglia in the wall of the esophagus.

Entities:  

Keywords:  Esophageal sphincter; Esophagus; Motility disorder; Motor dysphagia; Peristalsis

Mesh:

Year:  2012        PMID: 22791940      PMCID: PMC3386318          DOI: 10.3748/wjg.v18.i24.3050

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  82 in total

1.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

2.  Association between idiopathic achalasia and IL23R gene.

Authors:  A R de León; J P de la Serna; J L Santiago; C Sevilla; M Fernández-Arquero; E G de la Concha; C Nuñez; E Urcelay; A G Vigo
Journal:  Neurogastroenterol Motil       Date:  2010-03-31       Impact factor: 3.598

3.  Gastrointestinal transit and gastric acid secretion in patients with achalasia.

Authors:  V F Eckardt; J Krause; D Bolle
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

4.  HLA and enteric antineuronal antibodies in patients with achalasia.

Authors:  A Latiano; R De Giorgio; U Volta; O Palmieri; C Zagaria; V Stanghellini; G Barbara; A Mangia; A Andriulli; R Corinaldesi; V Annese
Journal:  Neurogastroenterol Motil       Date:  2006-07       Impact factor: 3.598

5.  Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus.

Authors:  L Raymond; B Lach; F M Shamji
Journal:  Histopathology       Date:  1999-11       Impact factor: 5.087

6.  PACAP and VIP inhibit pyloric muscle through VIP/PACAP-preferring receptors.

Authors:  H P Parkman; A P Pagano; J P Ryan
Journal:  Regul Pept       Date:  1997-08-29

7.  Genetic evaluation of ALADIN gene in early-onset achalasia and alacrima patients.

Authors:  Kee Wook Jung; In Ja Yoon; Do Hoon Kim; Jun-Won Chung; Kwi-Sook Choi; Kee Don Choi; Ho June Song; Gin Hyug Lee; Seung-Jae Myung; Jin-Ho Kim; Dhiraj Maskey; Myeung Ju Kim; Hwoon-Yong Jung
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

8.  Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.

Authors:  Yasmina Juarranz; Irene Gutiérrez-Cañas; Begoña Santiago; Mar Carrión; José L Pablos; Rosa P Gomariz
Journal:  Arthritis Rheum       Date:  2008-04

9.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

10.  Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis.

Authors:  J E Hollis-Moffatt; M E Merriman; R A Rodger; K A Rowley; P T Chapman; N Dalbeth; P J Gow; A A Harrison; J Highton; P B B Jones; J L O'Donnell; L K Stamp; T R Merriman
Journal:  Ann Rheum Dis       Date:  2008-07-22       Impact factor: 19.103

View more
  34 in total

1.  Fever, ulcers and joint pain: an incidental finding of oesophageal dysmotility.

Authors:  Charles Anwuzia-Iwegbu; Asma Fikree; Nicola Tufton
Journal:  BMJ Case Rep       Date:  2013-08-29

2.  Long-term outcomes of Heller's myotomy and balloon dilatation in childhood achalasia.

Authors:  Efstratios Saliakellis; Nikhil Thapar; Derek Roebuck; Fernanda Cristofori; Kate Cross; Edward Kiely; Joseph Curry; Keith Lindley; Osvaldo Borrelli
Journal:  Eur J Pediatr       Date:  2017-05-23       Impact factor: 3.183

Review 3.  Esophageal motility disorders: new perspectives from high-resolution manometry and histopathology.

Authors:  Hiroki Sato; Kazuya Takahashi; Ken-Ichi Mizuno; Satoru Hashimoto; Junji Yokoyama; Go Hasegawa; Shuji Terai
Journal:  J Gastroenterol       Date:  2017-11-13       Impact factor: 7.527

4.  Perforation following pneumatic dilation of achalasia cardia in a university hospital in northern India: A two-decade experience.

Authors:  Uday C Ghoshal; Arun Karyampudi; Abhai Verma; Hemanta K Nayak; Samir Mohindra; Nakul Morakhia; Vivek A Saraswat
Journal:  Indian J Gastroenterol       Date:  2018-08-18

5.  Mice that express farnesylated versions of prelamin A in neurons develop achalasia.

Authors:  Shao H Yang; Shiri Procaccia; Hea-Jin Jung; Chika Nobumori; Angelica Tatar; Yiping Tu; Yulia R Bayguinov; Sung Jin Hwang; Deanna Tran; Sean M Ward; Loren G Fong; Stephen G Young
Journal:  Hum Mol Genet       Date:  2015-02-04       Impact factor: 6.150

6.  Epidemiological analysis of achalasia in Japan using a large-scale claims database.

Authors:  Hiroki Sato; Hiroshi Yokomichi; Kazuya Takahashi; Kentaro Tominaga; Takeshi Mizusawa; Naruhiro Kimura; Yuzo Kawata; Shuji Terai
Journal:  J Gastroenterol       Date:  2019-01-03       Impact factor: 7.527

Review 7.  Family case of achalasia cardia: case report and review of literature.

Authors:  Yulia Viktorovna Evsyutina; Alexander Sergeevich Trukhmanov; Vladimir Trophimovich Ivashkin
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 8.  The management of esophageal achalasia: from diagnosis to surgical treatment.

Authors:  Adrian Dobrowolsky; P Marco Fisichella
Journal:  Updates Surg       Date:  2013-07-02

Review 9.  Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomes.

Authors:  Orla M O'Neill; Brian T Johnston; Helen G Coleman
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

10.  Imaging evaluation of dogs and cats with Dysphagia.

Authors:  Rachel E Pollard
Journal:  ISRN Vet Sci       Date:  2012-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.